OP
- Messages
- 5,721
- Reaction score
- 474
I read the Abstract but admit I didn't read the study itself. The results seem counterintuitive and contradict the information from the first post which stated, if I read and remember it correctly, that the QTc prolongation is dose dependent.
Hi uncfnp,
The study linked in the first post did in the Introduction section cite the August 2011 FDA Drug Alert which indicated that citalopram QTc prolongation was dose-dependent,. However, the more recent research published in the June 2013 issue of the American Journal of Psychiatry seems to cast doubt on this assertion.
You can read the following short, layman's language coverage of the large VAH study of the matter and tell me what you think --> New VA Study Takes Issue with FDA’s Warnings about Citalopram : U.S. Medicine .
In any event, on page 2 they go on to provide what I think is a very reasonable and prudent approach to the issue of dosage.
Have fun.
DocV